MyoVista wavECG for Health Screening

N/A

Waitlist Available

Led By Partho Sengupta, MD

Research Sponsored by Heart Test Laboratories, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline

Awards & highlights

Study Summary

This trial is testing a new device that may help detect heart problems. The study will be conducted on subjects who have been enrolled in prior registry studies.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Diagnostic Performance

Trial Design

1Treatment groups

Experimental Treatment

Group I: MyoVista wavECGExperimental Treatment1 Intervention

Single arm - subjects meeting the inclusion, exclusion and screening criteria will receive a MyoVista wavECG and a trans-thoracic echocardiogram.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Heart Test Laboratories, Inc.Lead Sponsor

3 Previous Clinical Trials

975 Total Patients Enrolled

Partho Sengupta, MDPrincipal InvestigatorRutgers Robert Wood Johnson Medical School

4 Previous Clinical Trials

1,272 Total Patients Enrolled

~17 spots leftby Jun 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.